Tokyo, Japan

Kanji Komatsu

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Kanji Komatsu

Introduction

Kanji Komatsu is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on glucokinase activators. With a total of 2 patents to his name, Komatsu continues to push the boundaries of medical science.

Latest Patents

One of his latest patents involves a glucokinase activator, which is a compound represented by a specific formula. This compound includes a carbon atom in the R-configuration, with various possible substituents such as hydrogen atoms, halogen atoms, amino groups, and more. Another patent also focuses on a glucokinase activator, represented by a similar formula, emphasizing the importance of these compounds in pharmaceutical applications.

Career Highlights

Throughout his career, Kanji Komatsu has worked with prominent companies in the pharmaceutical industry. Notable among these are Kyorin Pharmaceutical Co., Ltd. and Teijin Pharma Limited. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Kanji Komatsu has collaborated with esteemed colleagues in his field, including Yasumichi Fukuda and Yoshikazu Asahina. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of new inventions.

Conclusion

Kanji Komatsu's contributions to the field of pharmaceuticals through his patents on glucokinase activators highlight his innovative spirit and dedication to improving medical science. His work continues to inspire future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…